ROYALTY PHARMA PLC's ticker is RPRX and the CUSIP is G7709Q104. A total of 360 filers reported holding ROYALTY PHARMA PLC in Q4 2023. The put-call ratio across all filers is 0.70 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2024 | $250 | -93.8% | 9,516 | -93.3% | 0.00% | -93.8% |
| Q4 2023 | $4,009 | +39.0% | 142,790 | +34.2% | 0.02% | +33.3% |
| Q3 2023 | $2,884 | +100.8% | 106,363 | +127.4% | 0.01% | +100.0% |
| Q2 2023 | $1,436 | +1170.8% | 46,767 | +1388.4% | 0.01% | – |
| Q1 2023 | $113 | -100.0% | 3,142 | -87.2% | 0.00% | -100.0% |
| Q2 2022 | $1,033,000 | +2548.7% | 24,571 | +3042.1% | 0.01% | – |
| Q4 2020 | $39,000 | -73.3% | 782 | -77.4% | 0.00% | -100.0% |
| Q3 2020 | $146,000 | – | 3,461 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SIGULER GUFF ADVISERS, LLC | 6,761,970 | $263,446,000 | 59.92% |
| Memorial Sloan Kettering Cancer Center | 1,128,255 | $43,957,000 | 50.90% |
| Vantage Consulting Group Inc | 2,727,854 | $106,277,000 | 41.47% |
| Indie Asset Partners, LLC | 756,874 | $29,488,000 | 22.15% |
| Overbrook Management Corp | 723,250 | $28,178,000 | 6.25% |
| Brown University | 621,759 | $24,224,000 | 5.93% |
| Geo Capital Gestora de Recursos Ltd | 200,692 | $8,527,000 | 3.82% |
| Lagoda Investment Management, L.P. | 141,560 | $5,515,000 | 2.97% |
| Greytown Advisors Inc. | 131,143 | $5,109,000 | 2.47% |
| SUVRETTA CAPITAL MANAGEMENT, LLC | 2,025,610 | $78,918,000 | 2.41% |